COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Print ISSN:-2394-6369

Online ISSN:-2394-6377


Current Issue

Year 2020

Volume: 7 , Issue: 1

Article Access statistics

Viewed: 519

Emailed: 0

PDF Downloaded: 148

International Journal of Clinical Biochemistry and Research

Assessing the need for adjustment of first trimester screening markers in Diabetic Womenc

Full Text PDF Share on Facebook Share on Twitter

Author Details : T.Spandana, Jnankumar Chaudhuri, Santhi Silambanan

Volume : 2, Issue : 3, Year : 2015

Article Page : 190-193

Suggest article by email


Introduction & Objective: First trimester screening is done to detect aneuploidy pregnancies; the tests include serum Pregnancy Associated Plasma Protein A (PAPP A), free β subunit of human Chorionic Gonadotropin (β hCG) and Nuchal Translucency (NT) thickness. This study was done to compare serum PAPP A and free β hCG levels in diabetic and non-diabetic women with normal NT thickness, during first trimester aneuploidy screening and to assess the need for adjustment of screening markers in diabetic women.

Materials and Methods: The study design is cross-sectional involving 632 non diabetic and 55 diabetic women who underwent first trimester (11 to 13 weeks 6days) aneuploidy screening from January 2014 to June 2015 at Sri Ramachandra Medical Centre. Serum PAPP A and free β human chorionic gonadotropin were measured by solid phase, two site fluoroimmunometric assay.
Results: Results were analysed using SPSS software version 18. Serum PAPP A concentration in diabetic women were found to be significantly low compared to non-diabetic women (p < 0.000). There was no significant difference in free β hCG between two groups.
Conclusion: Significantly low MoM PAPP A in diabetic pregnant women may necessitate to consider for adjustment of PAPP A values while calculating individual aneuploidy risk.

Keywords: PAPP A, free beta hCG, anueploidy screening, Diabetes Mellitus.

How to cite : T.spandana, Chaudhuri J, Silambanan S, Assessing the need for adjustment of first trimester screening markers in Diabetic Womenc. Int J Clin Biochem Res 2015;2(3):190-193

Copyright © 2015 by author(s) and Int J Clin Biochem Res. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (